Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs UTI Healthcare Fund
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.1
2.22
NAV
₹23.22
₹319.55
Fund Started
06 Oct 2020
01 Aug 2005
Fund Size
₹191.85 Cr
₹1429.84 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year
15.01%
9.16%
3 Year
17.98%
20.14%
5 Year
12.64%
13.16%
Equity
99.91%
94.12%
Cash
-0.01%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.45% |
Divi's Laboratories Ltd. | 7.09% |
Eli Lilly And Co | 6.46% |
Apollo Hospitals Enterprise Ltd. | 5.25% |
Johnson & Johnson Ltd. | 4.45% |
Laurus Labs Ltd. | 4.44% |
Torrent Pharmaceuticals Ltd. | 4.38% |
Cipla Ltd. | 4.34% |
Max Healthcare Institute Ltd. | 4.19% |
Dr. Reddy's Laboratories Ltd. | 3.95% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
06 Oct 2020
01 Aug 2005
